To characterize the nuclear localization of RAD51, we began with the S33 cell line, a derivative of the human fibrosarcoma line HT1080 that carries an untagged RAD51 expression construct under the control of a doxycycline (dox)-repressible promoter (6). The gene discussed is RAD51; the disease is fibrosarcoma.